Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
NSABP Foundation Inc
ClinicalTrials.gov Identifier:
NCT00052169
First received: January 24, 2003
Last updated: December 13, 2007
Last verified: December 2007